Silver Book Fact

Improvements in QoL from TAVR in SAS patients

Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state) to 6.7 at one year, and 7.4 at four years post procedure.

Kovac J, Schuler G, Gerckens U, et al. Four-Year Experience with CoreValve Transcatheter Heart Valve. EuroInterven. 2016; 12(8): 1039-46.


Four-Year Experience with CoreValve Transcatheter Heart Valve
Publication Date
Kovac J, Schuler G, Gerckens U, et al
Volume & Issue
Volume 12, Issue 8
Read Full Resource


  • Innovative Medical Research
  • Human Value

Related Facts

  • Life expectancy and quality of life gains from AVR
    A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years…  
  • From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states
  • In 2010, ~67,500 SAVRs were performed in the U.S.
  • Survival rates of SAS patients ages 80+ with and without SAVR
  • Satisfaction with HVD Treatment
    Among treated heart valve disease (HVD), 96% express “full satisfaction” and 78% are “very satisfied” with their treatment.